Shangpharma Corp Stock Current Valuation
Valuation analysis of ShangPharma Corp helps investors to measure ShangPharma Corp's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
ShangPharma Corp Company Current Valuation Analysis
ShangPharma Corp's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current ShangPharma Corp Current Valuation | 86.32 M |
Most of ShangPharma Corp's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ShangPharma Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, ShangPharma Corp has a Current Valuation of 86.32 M. This is much higher than that of the sector and significantly higher than that of the Pharmaceutical Products industry. The current valuation for all United States stocks is notably lower than that of the firm.
ShangPharma Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ShangPharma Corp's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ShangPharma Corp could also be used in its relative valuation, which is a method of valuing ShangPharma Corp by comparing valuation metrics of similar companies.ShangPharma Corp is currently under evaluation in current valuation category among its peers.
ShangPharma Fundamentals
| Return On Asset | 0.02 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 86.32 M | |||
| Shares Outstanding | 335.54 M | |||
| Number Of Shares Shorted | 17.53 K | |||
| Price To Earning | 48.93 X | |||
| Price To Book | 1.16 X | |||
| Price To Sales | 1.29 X | |||
| Revenue | 111.6 M | |||
| Gross Profit | 36.1 M | |||
| EBITDA | 22.78 M | |||
| Net Income | 11.11 M | |||
| Cash And Equivalents | 40.34 M | |||
| Cash Per Share | 1.85 X | |||
| Total Debt | 754.98 K | |||
| Debt To Equity | 0.26 % | |||
| Current Ratio | 2.78 X | |||
| Cash Flow From Operations | 18.28 M | |||
| Short Ratio | 0.20 X | |||
| Earnings Per Share | 0.18 X | |||
| Price To Earnings To Growth | 1.33 X | |||
| Number Of Employees | 2.08 K | |||
| Beta | 1.43 | |||
| Market Capitalization | 135.41 M | |||
| Total Asset | 166.9 M | |||
| Retained Earnings | 33.01 M | |||
| Working Capital | 41.6 M | |||
| Current Asset | 72.35 M | |||
| Current Liabilities | 30.74 M |
Pair Trading with ShangPharma Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ShangPharma Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ShangPharma Corp will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Ryder System could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ryder System when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ryder System - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ryder System to buy it.
The correlation of Ryder System is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ryder System moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ryder System moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ryder System can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in ShangPharma Stock
If you are still planning to invest in ShangPharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ShangPharma Corp's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |